ATS GUIDELINES Bundle

FeNO for Asthma

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1438974

Contents of this Issue

Navigation

Page 2 of 3

➤ In patients with asthma in whom treatment is being considered, we suggest the use of FeNO in addition to usual care over usual care alone (conditional recommendation, low confidence in estimates of effect). Figure 1. FeNO Treatment for Individuals With Asthma Exacerbations High Asthma Control Low • Investigate further • Address confounders • Additional factors • Step up therapy • Favor type 2 treatment • Clinical judgement Exacerbations Low Asthma Controlled • Clinical judgement • Adjust management • Step down therapy • Clinical judgement • Consider step down • Unable to use FeNO to titrate therapy FeNO ppb LOW HIGH Conceptual framework for the use of FeNO to guide treament decitions for individuals with asthma. e decision to act upon an individual FeNO value in an individual patient requires that the clinician combine clinical judgement based on the preceived probability of benefit with particular attention to the key outcome measures such as exacerbation risks that were assessed in the full text guideline. Treatment

Articles in this issue

view archives of ATS GUIDELINES Bundle - FeNO for Asthma